Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ORKAMBI
- Bioequivalence and Food Effect Bioavailability Study of Lumacaftor Film-Coated Tablets
- Mutation-specific Therapy for the Long QT Syndrome
- Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials
- Functional Respiratory Imaging and Orkambi in CF
- Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi®.
- Personalized Theratyping Trial
- Trikafta in Cystic Fibrosis Patients
- GLPG2737 on Top of Orkambi in Subjects With Cystic Fibrosis
- Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
- A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF)
- The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia
- Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI
- ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor
- Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del
- Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis
- A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
- Effect of Lumacaftor-ivacaftor on Glucose Handling and Tolerance in Cystic Fibrosis Phe508del
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation
- Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients
Clinical trials list
click for details